
Scientists have developed a new class of antibiotics to treat drug-resistant bacteria that cause deadly infections in humans.
The novel antibiotic, Zosurabalpin, shows promising results in treating highly drug-resistant strains of Carbapenem-resistant Acinetobacter baumannii (CRAB) in mouse models, according to the study published in Journal Nature. The research was conducted by Roche Pharma Research and Early Development in Switzerland.